Tech Company Financing Transactions

Matchpoint Therapeutics Funding Round

Nextech, Norwest Venture Partners and Access Biotechnology participated in a $150 million Series B funding round for Matchpoint Therapeutics. The financing round closed on 10/7/2026.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Kendall Sq.
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.matchpointtx.com

Email Address

[email protected]

Overview

Our core values serve as the foundation for everything we do. Matchpoint brings together passionate drug hunters, deep technical experts, and seasoned company builders unified by the goal of developing precision covalent medicines that transform the lives of those impacted by serious disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Andre Turenne

        

Chief Scientific Officer

Jared Cumming

        

Chief Technical Officer

Mark Tebbe

        

Vice President

Wei Li

        

Vice President

Paul Renhowe

        

Vice President

Suresh Singh

        

VP - Operations

Christopher Hren

        

Browse more venture capital transactions:

Prev: 10/7/2026: Nearhuman venture capital transaction
Next: 10/7/2026: General Medicine venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary